Author

Mickael Begue

Observed names: M Begue, M Bégue, M. Begue, M. Bègue

Institution: Clinifutur

Observed institutions: Centre Georges François Leclerc, Centre Léon Bérard, Centre Eugène Marquis, Centre François Baclesse, Institut Claudius Regaud, Centre Oscar Lambret, Institut Bergonié, Institut Paoli-Calmettes, Clinifutur, Université de Rouen Normandie

ORCID: 0009-0007-8656-4083

Observed ORCID: 0009-0007-8656-4083

OpenAlex ID: A5113398322

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

2019 · Xavier Pivot, Gilles Romieu, et al. · The Lancet · 133

The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential

2023 · Youssef Slama, Franck Ah-Pine, et al. · International Journal of Molecular Sciences · 66

High-Dose-Rate Brachytherapy for Non–Small-Cell Lung Carcinoma: A Retrospective Study of 226 Patients

2010 · Maud Aumont–le Guilcher, Bernard Prevost, et al. · International Journal of Radiation Oncology*Biology*Physics · 52

Intérêt de la tomographie par émission de positons au [18F]-fluoro-2-désoxyglucose dans la détermination des volumes cibles de radiothérapie. Application à l'irradiation conformationnelle des cancers bronchiques non à petites cellules

2005 · J.-M. Bachaud, D. Marre, et al. · Cancer/Radiothérapie · 10

Neo-adjuvant treatment with erlotinb in squamous cell carcinoma head and neck (SCCHN) patients before surgery provides an opportunity to find predictive factors of response

2006 · J. Delord, F. Thomas, et al. · Journal of Clinical Oncology · 9

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

2024 · Youssef Slama, Gilles Baumont, et al. · Frontiers in Oncology · 3

The Potential of Human Pulmonary Mesenchymal Stem Cells as Vectors for Radiosensitizing Metallic Nanoparticles: An In Vitro Study

2024 · Angélique Arcambal, Axelle Septembre-Malaterre, et al. · Cancers · 2

Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation

2002 · AC Braud, MP Mathoulin Portier, et al. · Bone Marrow Transplantation · 2

Exclusive high dose rate brachytherapy (HDR-BT) for early stage non-small cell lung carcinoma: Results of a retrospective study in 226 patients

2007 · M. Aumont, M. A. Mahe, et al. · Journal of Clinical Oncology

Curiethérapie endobronchique (CEB) exclusive pour des carcinomes bronchiques non à petites cellules à développement uniquement endobronchique : résultats d’une étude rétrospective multicentrique de 199 patients

2006 · M. Aumont, L.B. Prévost, et al. · Revue des Maladies Respiratoires

Exclusive High-Dose-Rate Brachytherapy (HDR-BT) for Limited Non-Small Cell Lung Carcinoma: Results of a French Study in 199 Patients

2005 · M. Aumont-Le Guilcher, M.A. Mahe, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 11

Citation count: 277

H-index: 5

I10-index: 4